PH22882A - Novel b-lactam antibiotics - Google Patents
Novel b-lactam antibioticsInfo
- Publication number
- PH22882A PH22882A PH33309A PH33309A PH22882A PH 22882 A PH22882 A PH 22882A PH 33309 A PH33309 A PH 33309A PH 33309 A PH33309 A PH 33309A PH 22882 A PH22882 A PH 22882A
- Authority
- PH
- Philippines
- Prior art keywords
- novel
- lactam antibiotics
- lactam
- antibiotics
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/36—Methylene radicals, substituted by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP858785 | 1985-01-21 | ||
| JP1198685 | 1985-01-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH22882A true PH22882A (en) | 1989-01-19 |
Family
ID=26343130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH33309A PH22882A (en) | 1985-01-21 | 1986-01-21 | Novel b-lactam antibiotics |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4808711A (hu) |
| EP (1) | EP0189287B1 (hu) |
| JP (1) | JPS61267583A (hu) |
| KR (1) | KR930007417B1 (hu) |
| AU (1) | AU586215B2 (hu) |
| CA (1) | CA1277977C (hu) |
| DE (1) | DE3687279T2 (hu) |
| DK (1) | DK27486A (hu) |
| ES (1) | ES8706159A1 (hu) |
| HU (1) | HU202538B (hu) |
| IL (1) | IL77676A (hu) |
| NZ (1) | NZ214864A (hu) |
| PH (1) | PH22882A (hu) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE150507T1 (de) * | 1983-12-29 | 1987-02-26 | Mochida Pharmaceutical Co., Ltd., Tokio/Tokyo | Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutishe praeparate. |
| EP0210815A3 (en) * | 1985-07-25 | 1988-04-20 | Beecham Group Plc | 6-beta-(alpha-etherified oxyimino)-acylamino penicillanic-acid derivatives, their preparation and use |
| US5147871A (en) * | 1986-07-03 | 1992-09-15 | Hoffmann La-Roche, Inc. | Anti-bacterial cephalosporin compounds |
| ZA874696B (en) * | 1986-07-03 | 1988-01-04 | F. Hoffmann-La Roche & Co. Aktiengesellschaft | Acyl derivatives |
| FI872879A (fi) * | 1986-07-21 | 1988-01-22 | Sankei Yakuhin Kk | --laktamfoerening, foerfarande foer dess framstaellning, denna innehaollande laekemedelskomposition foer behandling av sjukdom med bakterieinfektion samt mellanprodukter foer dess syntes. |
| AT392969B (de) * | 1986-11-17 | 1991-07-25 | Sankei Yakuhin Kk | Beta-lactamverbindungen, verfahren zu ihrer herstellung, dieselben enthaltende pharmazeutischepraeparate zur behandlung von durch bakterien verursachte infektionskrankheiten |
| DK170088A (da) * | 1987-04-10 | 1988-10-11 | Hoffmann La Roche | Acylderivater |
| MC1921A1 (fr) * | 1987-04-10 | 1989-04-06 | Sankei Yakuhin Kk | Derives acyles |
| FI883320A (fi) * | 1987-08-07 | 1989-02-08 | Sankei Yakuhin Kk | --laktam, dess framstaellning och mellanprodukter foer dess framstaellning. |
| US5138066A (en) * | 1987-08-14 | 1992-08-11 | Hoffmann-La Roche, Inc. | Intermediates for cephalosporins with sulfur-containing oxyimino side chain |
| EP0303172A3 (de) * | 1987-08-14 | 1991-05-15 | F. Hoffmann-La Roche Ag | Oxyimino-Cephalosporine |
| US5073550A (en) * | 1987-08-14 | 1991-12-17 | Hoffmann-La Roche Inc. | Cephalosphorins with sulfur-containing oxyimino side chain |
| US5336768A (en) * | 1988-05-24 | 1994-08-09 | Hoffmann-La Roche Inc. | Antibacterial cephalosporin compounds |
| CS273349B2 (en) * | 1988-03-31 | 1991-03-12 | Hoffmann La Roche | Method of cephalosporin's new derivatives production |
| US5159077A (en) * | 1989-07-21 | 1992-10-27 | Hoffmann-La Roche Inc. | Penam antibacterial compounds |
| US5162523A (en) * | 1989-07-21 | 1992-11-10 | Hoffmann-La Roche Inc. | Cephalosporin antibacterial compounds |
| EP0492277A3 (en) * | 1990-12-20 | 1992-10-14 | F. Hoffmann-La Roche Ag | Cephalosporin derivatives |
| EP0550775A1 (en) * | 1992-01-07 | 1993-07-14 | F. Hoffmann-La Roche Ag | Cephalosporin derivatives |
| US5318781A (en) * | 1993-04-06 | 1994-06-07 | Hoffmann-La Roche Inc. | Absorption enhancement of antibiotics |
| US5599988A (en) * | 1994-12-22 | 1997-02-04 | Smithkline Beecham Corporation | Large scale preparation of 2,4-dihydroxybenzaldehyde using a variation of the Vilsmeierhaack reaction and isolated intermediates |
| DE19654920A1 (de) * | 1996-06-26 | 1998-01-08 | Gruenenthal Gmbh | Neue synthetische Catecholderivate, Verfahren zu ihrer Herstellung und ihre Verwendung |
| WO2013036783A2 (en) | 2011-09-09 | 2013-03-14 | Cubist Pharmaceuticals, Inc. | Methods for treating intrapulmonary infections |
| US8809314B1 (en) | 2012-09-07 | 2014-08-19 | Cubist Pharmacueticals, Inc. | Cephalosporin compound |
| US8476425B1 (en) | 2012-09-27 | 2013-07-02 | Cubist Pharmaceuticals, Inc. | Tazobactam arginine compositions |
| PE20160048A1 (es) | 2013-03-15 | 2016-02-12 | Merck Sharp & Dohme | Composiciones antibioticas de ceftolozano |
| US9320740B2 (en) | 2013-03-15 | 2016-04-26 | Merck Sharp & Dohme Corp. | Ceftolozane-tazobactam pharmaceutical compositions |
| US9872906B2 (en) | 2013-03-15 | 2018-01-23 | Merck Sharp & Dohme Corp. | Ceftolozane antibiotic compositions |
| AU2014233637A1 (en) | 2013-09-09 | 2015-03-26 | Merck Sharp & Dohme Corp. | Treating infections with ceftolozane/tazobactam in subjects having impaired renal function |
| US8906898B1 (en) | 2013-09-27 | 2014-12-09 | Calixa Therapeutics, Inc. | Solid forms of ceftolozane |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1476312A (en) * | 1974-06-03 | 1977-06-10 | Beecham Group Ltd | Penicillins and cephalosporins |
| US4091212A (en) * | 1976-11-26 | 1978-05-23 | E. R. Squibb & Sons, Inc. | Hydrazinocarbonylamino cephalosporins 3-heterocyclicthio 7-hydrazinocarbonylamino acetylamino cephalosporins |
| JPS609719B2 (ja) * | 1977-08-06 | 1985-03-12 | 武田薬品工業株式会社 | セフアロスポリン誘導体およびその製造法 |
| DE150507T1 (de) * | 1983-12-29 | 1987-02-26 | Mochida Pharmaceutical Co., Ltd., Tokio/Tokyo | Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutishe praeparate. |
-
1986
- 1986-01-17 EP EP86300307A patent/EP0189287B1/en not_active Expired - Lifetime
- 1986-01-17 NZ NZ214864A patent/NZ214864A/xx unknown
- 1986-01-17 DE DE8686300307T patent/DE3687279T2/de not_active Expired - Fee Related
- 1986-01-17 JP JP61006281A patent/JPS61267583A/ja active Pending
- 1986-01-17 AU AU52449/86A patent/AU586215B2/en not_active Ceased
- 1986-01-17 US US06/819,831 patent/US4808711A/en not_active Expired - Fee Related
- 1986-01-17 CA CA000499832A patent/CA1277977C/en not_active Expired - Fee Related
- 1986-01-20 KR KR1019860000306A patent/KR930007417B1/ko not_active IP Right Cessation
- 1986-01-20 DK DK27486A patent/DK27486A/da not_active Application Discontinuation
- 1986-01-20 HU HU86264A patent/HU202538B/hu not_active IP Right Cessation
- 1986-01-21 ES ES551071A patent/ES8706159A1/es not_active Expired
- 1986-01-21 PH PH33309A patent/PH22882A/en unknown
- 1986-01-21 IL IL8677676A patent/IL77676A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ214864A (en) | 1988-04-29 |
| KR930007417B1 (ko) | 1993-08-10 |
| DK27486A (da) | 1986-07-22 |
| ES551071A0 (es) | 1987-06-01 |
| ES8706159A1 (es) | 1987-06-01 |
| KR860005824A (ko) | 1986-08-13 |
| DK27486D0 (da) | 1986-01-20 |
| JPS61267583A (ja) | 1986-11-27 |
| CA1277977C (en) | 1990-12-18 |
| US4808711A (en) | 1989-02-28 |
| EP0189287A3 (en) | 1987-09-30 |
| IL77676A (en) | 1990-09-17 |
| EP0189287A2 (en) | 1986-07-30 |
| HUT41800A (en) | 1987-05-28 |
| AU586215B2 (en) | 1989-07-06 |
| AU5244986A (en) | 1986-07-24 |
| HU202538B (en) | 1991-03-28 |
| DE3687279T2 (de) | 1993-05-13 |
| DE3687279D1 (de) | 1993-01-28 |
| EP0189287B1 (en) | 1992-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0189287A3 (en) | Novel b-lactam antibiotics | |
| ZA862987B (en) | Carbapenem antibiotics | |
| GB2152504B (en) | Cephalosporin antibiotics | |
| GB2163745B (en) | Penam antibiotics | |
| SG109692G (en) | Antibiotics | |
| GB2166737B (en) | Cephalosporin antibiotics | |
| ZA859713B (en) | B-lactam antibiotics | |
| GB2183237B (en) | Carbapenem antibiotics | |
| AR245126A1 (es) | Un procedimiento para preparar antibioticos de 1-carbacefalosporinas y compuestos intermedios de aplicacion exclusiva en dicho procedimiento . | |
| GB2159515B (en) | Cephalosporin antibiotics | |
| GB2180238B (en) | Carbapenem antibiotics | |
| GB8518124D0 (en) | Cephalosporin antibiotics | |
| GB8627404D0 (en) | Cephalosporin antibiotics | |
| GB8531202D0 (en) | Cephalosporin antibiotics | |
| GB8526901D0 (en) | Cephalosporin antibiotics | |
| GB8526900D0 (en) | Cephalosporin antibiotics | |
| ZA86395B (en) | Novel beta-lactam antibiotics | |
| IE852247L (en) | Novel antibiotics | |
| IE853252L (en) | Beta-lactam antibiotics | |
| GB8510628D0 (en) | Antibiotics | |
| GB8525988D0 (en) | Cephalosporin antibiotics | |
| GB8521975D0 (en) | Cephalosporin antibiotics | |
| IE850002L (en) | Cephalosporin antibiotics | |
| IE851148L (en) | Cephalosporin antibiotics | |
| IE851622L (en) | Cephalosporin antibiotics |